Transcat, Inc. $TRNS Position Increased by Rice Hall James & Associates LLC

Rice Hall James & Associates LLC raised its holdings in shares of Transcat, Inc. (NASDAQ:TRNS) by 49.2% in the 4th quarter, Holdings Channel reports. The firm owned 35,502 shares of the scientific and technical instruments company’s stock after purchasing an additional 11,702 shares during the quarter. Rice Hall James & Associates LLC’s holdings in Transcat were worth $2,014,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently added to or reduced their stakes in the company. Lazard Asset Management LLC bought a new stake in Transcat during the second quarter valued at $54,000. Tower Research Capital LLC TRC increased its stake in Transcat by 245.5% during the second quarter. Tower Research Capital LLC TRC now owns 1,123 shares of the scientific and technical instruments company’s stock valued at $97,000 after purchasing an additional 798 shares during the last quarter. PNC Financial Services Group Inc. increased its stake in Transcat by 42.7% during the third quarter. PNC Financial Services Group Inc. now owns 1,530 shares of the scientific and technical instruments company’s stock valued at $112,000 after purchasing an additional 458 shares during the last quarter. Jones Financial Companies Lllp increased its stake in Transcat by 79.2% during the third quarter. Jones Financial Companies Lllp now owns 1,634 shares of the scientific and technical instruments company’s stock valued at $120,000 after purchasing an additional 722 shares during the last quarter. Finally, Marshall Wace LLP bought a new stake in Transcat during the fourth quarter valued at $236,000. Institutional investors own 98.34% of the company’s stock.

Analyst Ratings Changes

Several research firms have weighed in on TRNS. Weiss Ratings upgraded shares of Transcat from a “sell (d)” rating to a “sell (d+)” rating in a research note on Thursday, May 28th. Zacks Research upgraded shares of Transcat from a “strong sell” rating to a “hold” rating in a research note on Friday, May 15th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Transcat has a consensus rating of “Moderate Buy” and an average target price of $105.33.

Transcat Stock Down 1.1%

Transcat stock opened at $90.63 on Wednesday. The company has a 50-day simple moving average of $80.33 and a 200-day simple moving average of $71.49. The firm has a market capitalization of $846.57 million, a P/E ratio of 156.26 and a beta of 0.71. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.99 and a current ratio of 2.33. Transcat, Inc. has a one year low of $50.23 and a one year high of $94.76.

Transcat (NASDAQ:TRNS) last released its quarterly earnings results on Tuesday, May 26th. The scientific and technical instruments company reported $0.56 EPS for the quarter, topping the consensus estimate of $0.51 by $0.05. The business had revenue of $89.33 million during the quarter, compared to analyst estimates of $89.79 million. Transcat had a net margin of 1.62% and a return on equity of 5.84%. As a group, equities analysts expect that Transcat, Inc. will post 1.71 earnings per share for the current year.

Transcat Profile

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.